These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 18480102)

  • 1. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
    Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
    Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
    Sanderson K; Wescombe L; Kirov SM; Champion A; Reid DW
    Eur Respir J; 2008 Aug; 32(2):329-33. PubMed ID: 18480103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis.
    Davies G; Wells AU; Doffman S; Watanabe S; Wilson R
    Eur Respir J; 2006 Nov; 28(5):974-9. PubMed ID: 16899482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa.
    Williams HD; Zlosnik JE; Ryall B
    Adv Microb Physiol; 2007; 52():1-71. PubMed ID: 17027370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
    Gillham MI; Sundaram S; Laughton CR; Haworth CS; Bilton D; Foweraker JE
    J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
    Reid DW; Carroll V; O'May C; Champion A; Kirov SM
    Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis.
    Enderby B; Smith D; Carroll W; Lenney W
    Pediatr Pulmonol; 2009 Feb; 44(2):142-7. PubMed ID: 19148935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
    Schiller NL; Millard RL
    Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desulfurization of mucin by Pseudomonas aeruginosa: influence of sulfate in the lungs of cystic fibrosis patients.
    Robinson CV; Elkins MR; Bialkowski KM; Thornton DJ; Kertesz MA
    J Med Microbiol; 2012 Dec; 61(Pt 12):1644-1653. PubMed ID: 22918866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas siderophores in the sputum of patients with cystic fibrosis.
    Martin LW; Reid DW; Sharples KJ; Lamont IL
    Biometals; 2011 Dec; 24(6):1059-67. PubMed ID: 21643731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis.
    Stutz MD; Gangell CL; Berry LJ; Garratt LW; Sheil B; Sly PD;
    Eur Respir J; 2011 Mar; 37(3):553-8. PubMed ID: 20562125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
    Wilson CB; Jones PW; O'Leary CJ; Hansell DM; Cole PJ; Wilson R
    Eur Respir J; 1997 Aug; 10(8):1754-60. PubMed ID: 9272915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis.
    Kolpen M; Hansen CR; Bjarnsholt T; Moser C; Christensen LD; van Gennip M; Ciofu O; Mandsberg L; Kharazmi A; Döring G; Givskov M; Høiby N; Jensen PØ
    Thorax; 2010 Jan; 65(1):57-62. PubMed ID: 19846469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR; Pressler T; Koch C; Høiby N
    J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis.
    Amin R; Lam M; Dupuis A; Ratjen F
    Pediatr Pulmonol; 2011 Jun; 46(6):554-8. PubMed ID: 21337727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality in adults with cystic fibrosis.
    Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS
    Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008.
    Emerson J; McNamara S; Buccat AM; Worrell K; Burns JL
    Pediatr Pulmonol; 2010 Apr; 45(4):363-70. PubMed ID: 20232473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.